Vivos Therapeutics (VVOS) EBITDA Margin (QoQ) (2020 - 2026)
Vivos Therapeutics (VVOS) EBITDA Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.86 Bn | 195.26 Bn | 7.27 Bn |
| 2 | Stryker | 126.19 Bn | 122.72 Bn | 4.50 Bn |
| 3 | Medtronic | 118.36 Bn | 109.14 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.32 Bn | 72.78 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.72 Bn | 47.47 Bn | 1.35 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.18 Bn | 22.86 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Vivos Therapeutics | 4.96 Mn | 3.16 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,822.00 |
| Dec 31, 2025 | -9,710.00 |
| Sep 30, 2025 | 5,756.00 |
| Jun 30, 2025 | 255.00 |
| Mar 31, 2025 | -5,403.00 |
| Dec 31, 2024 | -736.00 |
| Sep 30, 2024 | -2,077.00 |
| Jun 30, 2024 | 6,295.00 |
| Mar 31, 2024 | 1,654.00 |
| Dec 31, 2023 | -1,698.00 |
| Sep 30, 2023 | 2,278.00 |
| Jun 30, 2023 | -328.00 |
| Mar 31, 2023 | 2,373.00 |
| Dec 31, 2022 | -2,615.00 |
| Sep 30, 2022 | 3,910.00 |
| Jun 30, 2022 | 1,575.00 |
| Mar 31, 2022 | -1,353.00 |
| Dec 31, 2021 | -4,761.00 |
| Sep 30, 2021 | -3,075.00 |
| Jun 30, 2021 | 848.00 |